Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Brinkmalm

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 17, 2019
Detection of α-Synuclein in Biological Samples Using Mass SpectrometryAnn Brinkmalm, Annika Öhrfelt, Payel Bhattacharjee, et al.
Molecular & Cellular Proteomics : MCP|January 21, 2024
Alzheimer's Disease Biomarker Analysis Using Targeted Mass SpectrometryJohan Gobom, Ann Brinkmalm, Gunnar Brinkmalm, et al.
Clinical Proteomics|March 1, 2016
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometrySimon Sjödin, Annika Öhrfelt, Gunnar Brinkmalm, et al.
Journal of Proteome Research|April 4, 2019
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's DiseasePayel Bhattacharjee, Annika Öhrfelt, Tammaryn Lashley, et al.
Proteomics. Clinical Applications|October 4, 2017
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian DisordersSimon Sjödin, Oskar Hansson, Annika Öhrfelt, et al.
Biomarker Insights|September 11, 2020
Fluid Biomarkers for Synaptic Dysfunction and LossElena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Journal of Neurochemistry|September 22, 2018
Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseasesAnn Brinkmalm, Erik Portelius, Gunnar Brinkmalm, et al.
Expert Review of Proteomics|September 26, 2017
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an updateErik Portelius, Gunnar Brinkmalm, Josef Pannee, et al.
Proteomics. Clinical Applications|October 14, 2017
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's DiseaseGunnar Brinkmalm, Simon Sjödin, Anja Hviid Simonsen, et al.
Biochimica Et Biophysica Acta|January 27, 2015
Explorative and targeted neuroproteomics in Alzheimer's diseaseAnn Brinkmalm, Erik Portelius, Annika Öhrfelt, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|February 17, 2019
Detection of α-Synuclein in Biological Samples Using Mass SpectrometryAnn Brinkmalm, Annika Öhrfelt, Payel Bhattacharjee, et al.
Molecular & Cellular Proteomics : MCP|January 21, 2024
Alzheimer's Disease Biomarker Analysis Using Targeted Mass SpectrometryJohan Gobom, Ann Brinkmalm, Gunnar Brinkmalm, et al.
Clinical Proteomics|March 1, 2016
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometrySimon Sjödin, Annika Öhrfelt, Gunnar Brinkmalm, et al.
Journal of Proteome Research|April 4, 2019
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's DiseasePayel Bhattacharjee, Annika Öhrfelt, Tammaryn Lashley, et al.
Proteomics. Clinical Applications|October 4, 2017
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian DisordersSimon Sjödin, Oskar Hansson, Annika Öhrfelt, et al.
Biomarker Insights|September 11, 2020
Fluid Biomarkers for Synaptic Dysfunction and LossElena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Journal of Neurochemistry|September 22, 2018
Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseasesAnn Brinkmalm, Erik Portelius, Gunnar Brinkmalm, et al.
Expert Review of Proteomics|September 26, 2017
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an updateErik Portelius, Gunnar Brinkmalm, Josef Pannee, et al.
Proteomics. Clinical Applications|October 14, 2017
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's DiseaseGunnar Brinkmalm, Simon Sjödin, Anja Hviid Simonsen, et al.
Biochimica Et Biophysica Acta|January 27, 2015
Explorative and targeted neuroproteomics in Alzheimer's diseaseAnn Brinkmalm, Erik Portelius, Annika Öhrfelt, et al.
Pageof 7